The Patent Trial and Appeal Board (“PTAB”) regularly tracks statistics regarding administrative trials conducted under the processes created by the America Invents Act (“AIA”), which provide insight into recent trends...more
8/25/2021
/ Abbreviated New Drug Application (ANDA) ,
America Invents Act ,
Biologics ,
BPCIA ,
Food and Drug Administration (FDA) ,
Orange Book ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Patents ,
Post-Grant Review ,
Purple Book ,
USPTO
On December 10, 2019, an agreement was reached between the United States, Mexico, and Canada on amendments to the U.S.-Mexico-Canada Agreement (“USMCA”). The USMCA, if ratified by each respective country, would replace the...more
12/18/2019
/ Biologics ,
Biotechnology ,
BPCIA ,
Copyright ,
Exclusivity ,
Exclusivity Rule ,
Foreign Entities ,
Intellectual Property Protection ,
NAFTA ,
Patent Term Extensions ,
Pharmaceutical Industry ,
Safe Harbors ,
Trade Associations ,
Trade Relations ,
United States-Mexico-Canada Agreement (USMCA)